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Introduction
Mosaic chromosome aberrations can be detected pre-
natally, and sex chromosome mosaicism is the most
frequently seen [1]. In sex chromosome mosaicism,
structural abnormalities (10.5%) are less common than
numerical abnormalities (89.5%) [1]. Among the re-
ported postnatal cases of mos45,X/46,X,+mar, the
marker chromosome was often derived from either 
a normal or abnormal X or Y chromosome. Clinically,
the phenotypes of such cases were determined not
only by the characterization of the aberrant Y chromo-
somes but also by the ratio and the distribution of
45,X cells [2]. It is supposed that a case with a 45,X
cell line has an increased risk of being a phenotypic
female or to have ambiguous external genitalia regard-
less of the presence of Yp, Yq, both Yp and Yq, or even a
normal Y chromosome in another cell line [2]. However,
it has also been proposed that some genes present on
the Y chromosome can avoid features of Turner syn-
drome and aid in male gonadal maturation and normal
spermatogenesis [3]. Cases of mos45,X/46,X,Y-derived
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SUMMARY
Objective: Prenatal diagnosis of mos45,X/46,X,+mar is difficult in genetic counseling. Patients with the presence
of a Y-derived marker may manifest male or female external genitalia. Here, we report a fetus with phenotypically
male external genitalia of mos45,X/46,X,+mar. In addition, the cases with prenatally detected mos45,X/
46,X,del(Y)(q11.2) and normal male external genitalia are reviewed.
Case Report: A 30-year-old, primigravid woman was referred for amniocentesis because of an abnormal Down
syndrome screening result at 20 weeks’ gestation. Cytogenetic analysis showed mos45,X/46,X,+mar without a
normal Y chromosome. Prenatal ultrasound detected symmetric intrauterine growth restriction and normal
male external genitalia. After termination of the pregnancy, a phenotypically normal male fetus was delivered
smoothly without apparent structural defects. Based on conventional G-banded analysis, the marker chromosome
appeared as a Y chromosome that originated with a deleted Yq, designated as del(Y)(q11.2).
Conclusion: Based on a literature review, the addition of fluorescence in situ hybridization and molecular analysis
to the conventional cytogenetic techniques can provide more accurate identification of a Y chromosome aber-
ration in the prenatal detection of mos45,X/46,X,+mar, thus allowing more appropriate genetic counseling for
the family. [Taiwan J Obstet Gynecol 2009;48(3):292–295]
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marker chromosomes have been reported to manifest
in a wide spectrum including female genitalia, ambigu-
ous genitalia, male external genitalia with gynecomastia,
short stature, and azoospermia, or even normal male
development [2,4,5]. Therefore, prenatal diagnosis of
mos45,X/46,X,+mar is difficult in the interpretation of
the results and in genetic counseling.
Here, we describe a fetus with phenotypically male
external genitalia with a karyotype of mos45,X/46,X,+
mar detected incidentally after a positive result of
maternal serum multiple-marker screening and intrauter-
ine growth restriction (IUGR). The marker chromosome
was designated as del(Y)(q11.2) based on conventional
G-banded analysis. In addition, the cases with prena-
tally detected mos45,X/46,X,del(Y)(q11.2) and normal
male external genitalia are reviewed.
Case Report
A 30-year-old primigravid woman was referred to 
our hospital for amniocentesis at 20 weeks’ gestation
because of a positive result on maternal serum multiple-
marker screening (1/146). At the same time, level II
ultrasound showed symmetric IUGR with a biparietal
diameter of 3.77cm (16 weeks), a femur length of 1.8cm
(< 15 weeks), and normal male external genitalia. No
associated structural malformations were detected. She
denied exposure to teratogenic materials or medications
during early pregnancy. Her husband was 34 years old.
The couple were healthy and nonconsanguineous. In
addition, the family history was unremarkable.
Cytogenetic analysis of cultured amniocytes revealed
mos45,X[23]/46,X,+mar[20] in different culture dishes
from in situ cultures (Figure). By conventional G-banded
analysis, the marker chromosome appeared as a Y chro-
mosome with Yq deletion, designated as del(Y)(q11.2).
After genetic counseling for the parents, they opted to
terminate the pregnancy at 24 weeks’ gestation because
of the possibility of fertility problems from the deleted
Yq segment and the possible associated abnormalities
caused by the presence of 45,X cells. The pregnancy was
terminated using intravaginal prostaglandin E1. A phe-
notypically normal male fetus was delivered smoothly
with a body weight of 342 g and no apparent structural
defects were detected. The placenta appeared normal
and weighed 180 g. Postnatal cytogenetic analysis of
the placenta showed mos45,X[2]/46,X,del(Y)(q11.2)[2]
and of cord blood showed mos46,X,del(Y)(q11.2)[42]/
45,X[8]. The parental karyotypes were unavailable.
Discussion
An aberrant Y chromosome leading to its instability
results in mosaic 45,X with partial or complete loss 
of the Y chromosome [6]. Cases with the karyotype 
of mos45,X/46,X,Y-derived marker can have variable
manifestations. Three females of 45,X/46,X,del(Y)(q12)
karyotype have been reported to have sexual infantilism,
short stature, and somatic Turner stigmata [4]. The
authors also reviewed cases of mos45,X/46,X,del(Yq)
whose sexual development was classified into three
categories: (1) female individuals with infantile sex and
Turner syndrome features, (2) individuals with ambigu-
ous genitalia, and (3) male individuals with azoospermia
[4]. Hsu [2] reported 38 postnatal cases of mos45,X/
46,X,del(Y)(q11) manifesting as phenotypic males in
13 cases (34.2%), intersex in 18 cases (47.4%), and
phenotypic females in seven cases (18.4%). Among the
13 phenotypic males, the associated anomalies included
short stature in eight cases and genital anomalies such
as small or abnormal testes in seven cases, hypospadia
in four cases, small penis in three cases, and gonadoblas-
toma in one case. It seemed that a case with mosaic
45,X had an increased risk of having ambiguous external
genitalia or of being a phenotypic female. In addition,
the presence of the Y-derived marker may be associated
with abnormalities of the external genitalia at birth,
lack of secondary sexual characteristics at puberty,
and/or development of gonadal tumors. Therefore, it
is difficult to interpret the chromosomal karyotype and
provide genetic counseling when prenatal diagnosis of
a mos45,X/46,X,del(Yq) karyotype is made.
Only a few postnatal cases of the karyotype of
mos45,X/46,X,del(Y)(q11.2) have been reported to have
normal male external genitalia [7–9]. There are even
fewer cases which were diagnosed prenatally. Here, 
we have summarized the prenatally detected cases of
mos45,X/46,X,del(Y)(q11.2) characterized by normal





Figure. Partial karyotype of the proband shows the abnormal
Y chromosome with a Yq11.2–qter deletion.
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the lack of significant fetal structural defects prenatally,
this mosaic sex chromosomal abnormality is usually
incidentally detected with different obstetric indications.
In the Table, all of the subjects were characterized with
normal male external genitalia, which may be associ-
ated with the increased ratio of the 46,X,del(Y)(q11) cell
line in the fetal cord blood, skin, gonads and spleen
(> 50%). In addition, we noted that the presence of
45,X cell line in amniocytes is not only from extra-
embryonic placentas but also from the embryonic tis-
sues. Therefore, Turner syndrome stigmata may occur
in the fetus such as in IUGR seen in our case. However,
the correlation between the 45,X cell line and IUGR
still remains controversial, because the ratio of 45,X
was not higher than that of the other two cases which
had normal fetal growth. More accurate identification
of the ratio and the distribution of 45,X cells in different
tissues by genetic dosage analyses might be required
to explain the possible correlation.
The human Y chromosome is widely considered to
be a morphologic variation and contains only a few
genes known to be important for normal male devel-
opment, such as the sex-determining region of the Y
chromosome (SRY gene). Some genes on the deleted
Yq11 segment are critical for normal germ cell devel-
opment, such as the azoospermia factor (AZF) gene on
Yq11.2. The gene is separated into four sub-regions
including AZFa on Yq11.21, AZFb on Yq11.22, AZFd,
and AZFc on Yq11.23 [11]. AZFd is located between
AZFb and AZFc. Complete or partial deletions of these
sub-regions may be related to abnormal gonadal devel-
opment, including a complete absence of germ cells
(also called Sertoli-cell-only syndrome; AZFa), a meiotic
maturation arrest of spermatogenesis (AZFb), and the
presence of variable testicular pathology (AZFc) [12].
Despite the fact that the exact correlation between
genotypes and phenotypes remains to be elucidated,
more severe phenotypes associated with abnormal sper-
matogenesis will occur with the presence of more dele-
tions on Yq11.2 [13,14]. The distal Yq (Yq12) contains
constitutive heterochromatin; it is genetically inactive,
and cases with only deleted Yq12 regions can expect
Table. Prenatally detected cases of mos45,X/46,X,del(Y)(q11.2) with normal external male genitalia
Case 1 [9] Case 2 [10] Current case
Maternal age (yr) 29 32 30 
Paternal age (yr) NA 36 34
G, P and A G2P0A1 G3P1 G1P0
Indications PPROM AMA MSS and IUGR
Gestational age (wk) 18 18 20
Diagnosis
G-banded (+) (+) (+)
FISH (+) (+) (−)
Microsatellite (+) (+) (−)
Multiplex PCR (+) (+) (−)
Parental karyotype Normal Normal NA
External genitalia Normal male Normal male Normal male
Final karyotype 46,X,del(Y)(q11.23)/45,X 46,X,del(Y)(q11.2)/45,X 46,X,del(Y)(q11.2)/45,X
Mosaic ratio 
(46,X, + mar/45,X)
Amniocytes 65/110 (37.1%) 52/19 (73.2%), 12/12 (50.0%)* 20/23 (46.5%)
Cord blood 81/21 (79.4%) (−) 42/8 (84.0%)
Villi 4/5 (44.4%) 17/5 (77.3%) 2/2 (50.0%)
Skin 90/10 (90.0%) (−) (−)
Gonads (−) 14/7 (66.7%) (−)
Spleen (−) 14/7 (66.7%) (−)
Outcome Alive and normal development Terminated Terminated
at 5 years old
*Repeat amniocentesis results. NA = not available; G = gravidity; P = parity; A = abortion; PPROM = preterm premature rupture of membranes; AMA =
advanced maternal age; MSS = an elevated result of maternal serum screening; IUGR = intrauterine growth restriction; (+) = done; (−) = not done; FISH =
fluorescence in situ hybridization; PCR = polymerase chain reaction.
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no phenotypic effects unless the euchromatic Yq is also
deleted. In the Table, both the reported cases were ana-
lyzed using fluorescence in situ hybridization initially,
and the marker chromosome was identified to be of Y
chromosome origin. Subsequently, molecular diagnostic
tools using microsatellite markers or multiplex poly-
merase chain reaction characterized the detailed Yq
deletion. These tools are helpful in identifying the nature
and origin of unknown markers and rearrangements
which have important implications in sexual differenti-
ation. Case 1 had a deleted segment of Yq11.23–Yqter
involving the AZFc sub-region only, and normal male
development was documented at 5 years of age. Case 2
had the breakpoint at Yq11.21 (AZFa)–Yq11.22 (AZFb),
which might be associated with future infertility of the
proband. In this case, we proposed that the marker
chromosome was of Y chromosome origin because of
the presence of male external genitalia but the absence
of a normal Y chromosome, and then the breakpoint,
designated as del(Y)(q11.2), was determined using a
G-banding ideogram. However, we could not exactly
determine the deleted region without the introduction
of any molecular analyses. Mezei et al [15] reported
that the major determinant of parental decision making
toward termination of a pregnancy with sex chromo-
some aneuploidy was the possibility of abnormal sexual
development or infertility in the child [15]. Therefore,
prenatal application of a reliable molecular method
for detailed analysis of this Y-derived marker chromo-
some, such as the AZF region on Yq11.2, is clinically
important to provide appropriate genetic counseling
to the family.
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